iShares Core MSCI EAFE ETF IEFA
About this Fund
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is designed to measure large-, mid- and small-capitalization equity market performance and includes stocks from Europe, Australasia and the Far East.
Investment Strategy & Highlights
- Theme: Tracks EAFE (Core).
- Category: Foreign Large Blend · managed by iShares.
- Diversification: 10 top holdings reported; the top 10 positions account for 11.4% of the portfolio.
- Largest position: ASML Holding NV (ASML.AS) at 2.21%.
- Top sector: Financial Services at 22.9% of holdings.
- Geographic exposure: United Kingdom (3.4%), Switzerland (3.3%), Netherlands (2.2%), Germany (0.9%), Australia (0.8%) .
- Cost: Expense ratio of 0.07% — very low for this category.
- Income: Distributes a yield of approximately 3.32%.
- Track record: 3Y avg +18.08% · 5Y avg +8.48% per year.
- Trading: Listed on BTS, denominated in USD.
Geographic Allocation
| Country / Region | Weight % |
|---|---|
| United Kingdom | 3.43% |
| Switzerland | 3.28% |
| Netherlands | 2.21% |
| Germany | 0.89% |
| Australia | 0.83% |
| Japan | 0.80% |
Inferred from the listing exchange of each top holding; the underlying fund may invest beyond the holdings shown here.
Curated from issuer disclosures, fund factsheets, and public market data. Figures are illustrative and not investment advice.
Key Facts
Performance Returns
Total price return over each window. 3Y/5Y use weekly close history; shorter windows use daily closes.
Risk & Volatility
Volatility = stdev of daily returns × √252. Sharpe-like = annualized mean / annualized vol (rf = 0%). Educational estimates from 1-year price history.
Technical Trend
Signal: Bullish (price > SMA50 > SMA200)
Computed from daily close history. SMA-50 above SMA-200 is the classic “golden cross” trend regime. RSI > 70 overbought · RSI < 30 oversold.
PROS
- Very low expense ratio (0.07%) — cost-efficient core holding.
- Large AUM (~$180.7B) — deep liquidity and tight spreads.
- Attractive risk-adjusted return (Sharpe~1.48).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from fund metrics.
Price Chart
Top Holdings (10)
| # | Symbol / CUSIP | Name | Weight % |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | +2.21% |
| 2 | HSBA.L | HSBC Holdings PLC | +1.25% |
| 3 | AZN.L | AstraZeneca PLC | +1.17% |
| 4 | ROP.SW | Roche Holding AG Ordinary Shares new | +1.14% |
| 5 | NOVN.SW | Novartis AG Registered Shares | +1.12% |
| 6 | NESN.SW | Nestle SA | +1.03% |
| 7 | SHEL.L | Shell PLC | +1.02% |
| 8 | SIE.DE | Siemens AG | +0.89% |
| 9 | CBA.AX | Commonwealth Bank of Australia | +0.83% |
| 10 | 8306.T | Mitsubishi UFJ Financial Group Inc | +0.80% |
Top holdings as reported by the fund issuer; full list of constituents may not be available.
Sector Allocation
Latest News
Recent headlines for IEFA